DOI:
10.1055/s-00035024
Thrombosis and Haemostasis
LinksClose Window
References
Denzinger V, Busygina K, Jamasbi J. , et al.
Optimizing platelet GPVI inhibition versus hemostatic impairment by ibrutinib and the novel Btk-inhibitors acalabrutinib, ONO/GS-4059, BGB-3111 and evobrutinib.
Thromb Haemost 2019;
119 (03) 397-406
Access:
We do not assume any responsibility for the contents of the web pages of other providers.